Announcements Trials

Browse Landscape

Phase

Status

Recruiting 5 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

pembrolizumab 437 Carboplatin 322 Nivolumab 291 Cyclophosphamide 281 Specimen Handling 271 Magnetic Resonance Spectroscopy 257 Cisplatin 254 Paclitaxel 247 Radiotherapy 230 Gemcitabine 183 Dexamethasone 182 Biopsy 182 durvalumab 168 atezolizumab 150 Rituximab 138 Doxorubicin 135 Lenalidomide 134 Bevacizumab 132 Ipilimumab 130 Docetaxel 129 Capecitabine 120 Radiation 119 Radiosurgery 113 Oxaliplatin 113 Pemetrexed 112 Etoposide 111 Fluorouracil 109 venetoclax 107 fludarabine 106 Prednisone 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glutamyl Aminopeptidase × Clear all

NCT05415527 2026-01-29

OPTIMOVA

Institut Bergonié

Phase NA Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡